Stay updated on Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial page.

Latest updates to the Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe Locations sections were reorganized into a consolidated Locations listing including country codes (BG, BO, BR, BS, CN, CT, FE, GE, GR, LU, MI, MO, PA, PD, PN, PO, PR, PZ, RE, TN, TO, TV, UD, VE, VR) and a new Revision: v3.3.3 was added, while prior v3.3.2 location blocks and the HHS Vulnerability Disclosure item were removed.SummaryDifference2%

- Check20 days agoChange DetectedRecruitment status changed from Active, not recruiting to Completed, and the completion date along with an estimated 'Last Update Posted' timestamp were added to the page.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page shows Revision: v3.3.2, replacing the previous v3.2.0. This appears to be a backend version update with no substantive changes to trial details, eligibility criteria, locations, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedA government funding status notice banner was removed from the page, removing the funding update text. This is a minor content change that does not affect the trial details, eligibility criteria, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedThe Study Details page shows no significant changes; content and layout appear unchanged.SummaryDifference0.2%

- Check91 days agoChange DetectedUpdated the page to announce v3.2.0 and to inform users about potential site access/transaction limitations due to funding gaps, while confirming the NIH Clinical Center is open and where to check status.SummaryDifference2%

Stay in the know with updates to Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial page.